These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Zhu Y, Yang J, Xu D, Gao XM, Zhang Z, Hsu JL, Li CW, Lim SO, Sheng YY, Zhang Y, Li JH, Luo Q, Zheng Y, Zhao Y, Lu L, Jia HL, Hung MC, Dong QZ, Qin LX. Gut; 2019 Sep 01; 68(9):1653-1666. PubMed ID: 30902885 [Abstract] [Full Text] [Related]
11. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2. Li H, Huang N, Zhu W, Wu J, Yang X, Teng W, Tian J, Fang Z, Luo Y, Chen M, Li Y. BMC Cancer; 2018 May 22; 18(1):579. PubMed ID: 29783929 [Abstract] [Full Text] [Related]
13. Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages. Jiang C, Yuan F, Wang J, Wu L. Immunobiology; 2017 Apr 22; 222(4):651-657. PubMed ID: 28017495 [Abstract] [Full Text] [Related]
14. Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling. Xu F, Cui WQ, Wei Y, Cui J, Qiu J, Hu LL, Gong WY, Dong JC, Liu BJ. J Exp Clin Cancer Res; 2018 Aug 29; 37(1):207. PubMed ID: 30157903 [Abstract] [Full Text] [Related]